Faculty Collaboration Database

How a collaborative task force can assist in managing biotechnology products. Hosp Formul 1994 Jul;29(7):526-30, 533

Date

07/01/1994

Pubmed ID

10135146

Scopus ID

2-s2.0-0028246992 (requires institutional sign-in at Scopus site)

Abstract

The rapid expansion of biotechnology-derived pharmaceuticals into the health care system presents new challenges and concerns in formulary selection, development of usage guidelines, and budgeting. A DUE/QA pharmacy network and a hospital association in a metropolitan area formed a Biotechnology Task Force, whose goals included: developing a forum for practitioners and administrators to exchange information; applying a strategy for evaluating and predicting usage patterns; promoting educational endeavors; and developing database technology to assist institutions with usage monitoring. The task force successfully educated health care professionals and administrators about the ramifications of biopharmaceuticals. Having this process defined will prove beneficial for future evaluation of other biopharmaceuticals.

Author List

MacKinnon GE 3rd

Author

George MacKinnon PhD Founding Dean, Professor in the School of Pharmacy Administration department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Adverse Drug Reaction Reporting Systems
Antibodies, Monoclonal
Biotechnology
Drug Utilization Review
Education, Pharmacy, Continuing
Forms and Records Control
Hospitals, Urban
Illinois
Interprofessional Relations
Missouri
Organizational Affiliation
Pharmacy Service, Hospital
Quality Assurance, Health Care
Recombinant Proteins
Technology Assessment, Biomedical